Plan delivery and postnatal 1,2,3 care, liaise and refer where appropriate. Haematological disorders 1,2 (11.13) Sickle cell disease (11.13) (11.13) (11.13) Review the genetics, presentation and With appropriate liaison RCOG Patient 1,2 1,2,3 management of sickle cell disease in manage women with sickle cell information pregnancy with particular emphasis on disease demonstrating an (2014) Sickle cell treatment options and the potential for understanding of how risks disease in sickle cell crises. may be minimised both pregnancy. antenatally and intrapartum. (11.13) STRATOG Understand the role of the Be able to explain these risks Advanced, 1,3 haematologist in managing the in a manner that is easy to Maternal conditions. understand. Medicine eLearning: Sickle Cell Disease (2016) Haematological disorders 1,2 (11.14) Thrombophilia (11.14) (11.14) (11.14) Understand the genetic basis Conduct an appropriate history RCOG top 1,2 pathogenesis investigation and and examination from a guideline No. diagnosis of congenital and acquired woman with known 37a and No 37b. thrombophilias thrombophilia or suspected (2015) venous thromboembolism in Thrombosis and 1,2 pregnancy. embolism in Be able to quantify the risk of venous pregnancy. thromboembolism. Understand the risks 1,2,3 No.40 (2010) secondary to thrombosis, both fetal and Be able to liaise appropriately, Venous maternal. arrange and interpret suitable investigations and plan 1,2 and hormonal subsequent care. Understand how risks may be contraception. minimised and monitored. Be able to explain the condition and plan antenatal and
Plan delivery and postnatal care, liaise and refer where appropriate. 1,2,3 Haematological disorders (11.13) Sickle cell disease 1,2 (11.13) Review the genetics, presentation and management of sickle cell disease in pregnancy with particular emphasis on treatment options and the potential for sickle cell crises. (11.13) Understand the role of the haematologist in managing the conditions. 1,2 1,3 (11.13) With appropriate liaison manage women with sickle cell disease demonstrating an understanding of how risks may be minimised both antenatally and intrapartum. Be able to explain these risks in a manner that is easy to understand. 1,2,3 (11.13) RCOG Patient information (2014) Sickle cell disease in pregnancy. STRATOG Advanced, Maternal Medicine eLearning: Sickle Cell Disease (2016) Haematological disorders (11.14) Thrombophilia 1,2 (11.14) Understand the genetic basis pathogenesis investigation and diagnosis of congenital and acquired thrombophilias Be able to quantify the risk of venous thromboembolism. Understand the risks secondary to thrombosis, both fetal and maternal. Understand how risks may be minimised and monitored. 1,2 1,2 1,2 (11.14) Conduct an appropriate history and examination from a woman with known thrombophilia or suspected venous thromboembolism in pregnancy. Be able to liaise appropriately, arrange and interpret suitable investigations and plan subsequent care. Be able to explain the condition and plan antenatal and 1,2,3 (11.14) RCOG top guideline No. 37a and No 37b. (2015) Thrombosis and embolism in pregnancy. No.40 (2010) Venous and hormonal contraception.